Study of Antimicrobial Utilization and Cost of Therapy in Medicine Intensive Care Unit of a Tertiary Care Hospital in Eastern India
Sheikh Nurul Iqbal
Keywords :
Antibiotics, Cost analysis, Drug utilization study, Multidrug resistant
Citation Information :
Iqbal SN. Study of Antimicrobial Utilization and Cost of Therapy in Medicine Intensive Care Unit of a Tertiary Care Hospital in Eastern India. Indian J Crit Care Med 2020; 24 (10):938-942.
Introduction: High utilization of antimicrobial agent (AMA) and inappropriate usage in an intensive care unit (ICU) intensifies resistant organism, morbidity, mortality, and treatment cost. Prescription audit and active feedback are a proven method to check the irrational prescription. To analyze and compare the utilization of drugs, World Health Organization (WHO) proposed daily defined dose (DDD)/100 patient days and days of therapy (DOT)/100 patient days to measure utilization of AMAs. Data of AMAs utilization are required for planning an antibiotic policy and for follow-up of intervention strategies. Materials and methods: A prospective observational study was conducted for 1 year from July 2018 to June 2019 and the data obtained from ICU of a tertiary care hospital. The demographic data, the disease data, and the utilization of different classes of AMAs [WHO–Anatomical Therapeutic Chemical (ATC) classification] as well as their cost were recorded. Total number of patient days, DDD, DDD/100 patient days, and DOT/100 patient days were calculated as proposed by WHO. Statistical analysis was performed using statistical software SPSS version 25.0. The descriptive analysis was performed using summary statistics median [interquartile range (IQR)]. Results: A total 939 were included, out of them 332 (35.4%) were female. The median age of the total patients was 58 (45–70). The median length of stay in ICU was 3 days. Mortality rate during our study period was 38.6%. The highly utilized AMAs in our study was ceftriaxone (36.95 DDD/100 patient days) followed by piperacillin/tazobactam (31.57), meropenem (26.4), doxycycline (21.53), and polymyxin B (21.38). The association between APACHE II and SOFA score with use of restricted antibiotics found to be statistical significant (p value 0.018 and 0.000, respectively). The cost of antibiotics per patients and patient days were $449.97 and $93.77, respectively, while median value of total cost was $2,343.26. Conclusion: Ceftriaxone was the highest utilized AMA. The risk of receiving restricted antibiotics intensified with increasing prevalence of multidrug resistance bacteria and associated comorbidities. High treatment cost is responsible for higher utilization of restricted antibiotics in ICU.
World Health Organization. Community based surveillance of Antimicrobial use and resistance in resource constrained settings. 2009.
Anand N, Nayak IMN, Advaitha MV, Thaikattil NJ, Kantanavar KA, Anand S. Antimicrobial agents’ utilization and cost pattern in an intensive care unit of a teaching hospital in south India. Indian J Crit Care Med 2016;20(5):274–279. DOI: 10.4103/0972-5229.182200.
ICMR. IC of MRI. Hospital Infection Control Guidelines. Indian Council of Medical Research Antimicrobial Stewardship Program. 2017;62.
Krivoy N, El-ahal WA, Bar-lavie Y, Haddad S. Antibiotic prescription and cost patterns in a general intensive care unit. Pharm Pract (Granada) 2007;5(2):67–73.
Reder BL, Nielsen SL, Magnussen P, Engquist A, Frimodt-møller N. Antibiotic usage in an intensive care unit in a danish university hospital. J Antimicrob Chemother 1993;32(4):633–642. DOI: 10.1093/jac/32.4.633.
Dukes MN. Drug utilization studies. Methods and uses. Introduction. World Heal Organ Reg Publ Eur Ser 1993;45:1–4.
Cruz J, Izquierdo JM, Navarro DJ, Navarro-Salas J. Free fields via canonical transformations of matter-coupled two-dimensional dilaton gravity models. Phys Rev D 1998;58:044010. DOI: 10.1103/PhysRevD.58.044010.
John LJ, Devi P, John J, Guido S. Drug utilization study of antimicrobial agents in medical intensive care unit of a tertiary care hospital. Asian J Pharm Clin Res 2011;4(2):81–84.
Amit GS. Drug use evaluation study in a tertiary care corporate hospital with special Reference to use of antibiotics in ICU department. Int J Adv Pharmacy, Biol Chem 2013;2(1):179–189.
Shankar PR, Partha P, Dubey AK, Mishra P, Deshpande VY. Intensive care unit drug utilization in a teaching hospital in Nepal. Kathmandu Univ Med J 2005;3(2):130–137.
Biswal S, Mishra P, Malhotra S, Puri GD, Pandhi P. Drug utilization pattern in the intensive care unit of a tertiary care hospital. J Clin Pharmacol 2006;46(8):945–951. DOI: 10.1177/0091270006289845.
Williams A, Mathai AS, Phillips AS. Antibiotic prescription patterns at admission into a tertiary level intensive care unit in northern India. J Pharm Bioallied Sci 2011;3(4):531–536. DOI: 10.4103/0975-7406.90108.
Panda RK, Abhisek PA, Sika LM, Pradhan SS, Routray SS, Mohanty S. Utilisation of antimicrobial agents in intensive care unit at a tertiary care teaching hospital in eastern India. Int J Basic Clin Pharmacol 2019;8(9):1951. DOI: 10.18203/2319-2003.ijbcp20193672.
Usluer G, Ozgunes I, Leblebicioglu H, Akalin H, Ayaz C, Caylan R, et al. A multicenter point prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob 2005;4:1–5. DOI: 10.1186/1476-0711-4-16.
Weber RJ, Kane SL, Oriolo VA, Saul M, Skledar SJ, Dasta JF. Costs and Charges. Crit Care Med 2003;31(1):17–24. DOI: 10.1097/00003246-200301001-00003.
